Crescent Capital BDC
CCAP · NASDAQ
About CCAP
- Employees
- 256
- Headquarters
- Los Angeles, California
- Listed
- Feb 3, 2020
- Sector
- Financials
- Industry
- Capital Markets
- Website
- crescentbdc.com
CCAP key statistics
- Market cap
- 317.61M
- Price-earnings ratio
- 11.01
- Dividend yield
- 20.46%
- Average volume
- 254.84K
- Volume
- 227.82K
- Open price
- $8.70
- High today
- $8.84
- Low today
- $8.61
- 52 Week high
- $15.18
- 52 Week low
- $8.68
Crescent Capital BDC (CCAP) at a glance
Crescent Capital BDC (CCAP) last traded at $8.62, with a market cap of 317.61M, a price-to-earnings ratio of 11.01 and a dividend yield of 20.46%.
Today the stock has traded between $8.61 and $8.84. The current price is 0.2% above the day's low and 2.4% below its high.
Volume so far is 227.82K shares, in line with the average of 254.84K shares a day.
Over the past year Crescent Capital BDC has ranged from $8.68 to $15.18, and now sits -1% of the way up that range.
Crescent Capital BDC met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.36 per share against an estimate of $0.3759.
The average analyst price target is $12.91, 49.8% above the current price, from 6 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy16.7%
- Hold83.3%
- Sell0.0%
- Low
- $10.35
- Now
- $8.62
- High
- $16.27
CCAP earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 5.3% on average.
- Q3 FY24: reported $0.64 per share against an estimate of $0.5847
- Q4 FY24: reported $0.55 per share against an estimate of $0.5746
- Q1 FY25: reported $0.45 per share against an estimate of $0.5352
- Q2 FY25: reported $0.46 per share against an estimate of $0.4767
- Q3 FY25: reported $0.46 per share against an estimate of $0.4798
- Q4 FY25: reported $0.45 per share against an estimate of $0.4449
- Q1 FY26: reported $0.42 per share against an estimate of $0.4261
- Q2 FY26: reported $0.36 per share against an estimate of $0.3759
CCAP news
- Press releaseBusiness Wire
What Analysts Are Saying About Crescent Capital BDC Stock
- Press releaseBusiness Wire
Crescent Capital Group Appoints Jason Breaux as Head of Private Credit
What Analysts Are Saying About Crescent Capital BDC Stock
Crescent Capital BDC Earnings Preview
The Analyst Landscape: 4 Takes On Crescent Capital BDC
Analyst Expectations For Crescent Capital BDC's Future
Key Takeaways From Crescent Capital BDC Analyst Ratings
Similar companies
Companies in the same industry as Crescent Capital BDC
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.